2

3

4

5

6

7

8

9

10

11

12

13

Sequential V/S Integrated DoE

Reduce• variables• toxicity• costs

Improve• activity• specificity• efficacy

BioGlobaX

14

15

16

17

18

Acknowledgments

Slav Dimov, M.Sc., BioGlobaX Inc., CanadaProf. Deborah Zamble, University of Toronto, CanadaProf. Emil Pai, University of Toronto, CanadaAiping Dong, MSc, University of Toronto, CanadaDr. Robert Lam, University of Toronto, CanadaProf. Cheryl Arrowsmith, University of Toronto, CanadaProf. Aled Edwards, University of Toronto, CanadaProf. Hee-Won Park, University of Toronto, CanadaProf. Martin Högbom, Stockholm University, SwedenProf. Atanass Atanassov, Sofia University, BulgariaProf. Ivan Ivanov, Institute of Mol. Biology, BulgariaDr. Roumjana Mironova, Inst. of Mol. Biology, BulgariaDr. Genoveva Nacheva, Inst. of Mol. Biology, BulgariaDr. Tamara Paipanova, Inst. of Mol. Biology, BulgariaProf. Masahiro Sugiura, Nagoya University, JapanProf. Mamoru Sugita, Nagoya University, JapanProf. Toshimitsu Niw, Nagoya University, Japan

BioGlobaX